Milestone Pharmaceuticals Inc. announced an investor event on February 25, 2025, in New York to discuss its commercial launch plan for etripamil nasal spray, also known as CARDAMYST™, which is ...

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and ...

Twenty years ago, in 2004, Congress passed the Project BioShield Act, which established the Biomedical Advanced Research and ...

Nasal Spray Flu Vaccine Candidate Shows Promise ... in unpasteurized milk is stable on metal and rubber components of commercial milking equipment for at least one hour, increasing its potential ...

China has reported two more H9N2 avian flu infections in humans, both of them patients from Hunan province in the southern ...

Jennifer Bliska is a project director with Hernando Community Coalition (HCC). Their goal is to enhance the health and ...

The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...

STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...

The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.